<DOC>
	<DOCNO>NCT00810940</DOCNO>
	<brief_summary>This randomize , control clinical trial three site determine safety preliminary efficacy study drug treat severe head trauma ( GCS 4-8 ) . It hypothesize drug may lower pressure brain , reduce mortality patient may improve neurological function follow treatment .</brief_summary>
	<brief_title>Controlled Trial ABELADRUG200 Closed , Severe Head Injury</brief_title>
	<detailed_description />
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Diagnosis TBI GCS 48 Age 1670 Multiple trauma result shock Bilateral absent pupil response Time injury &gt; 6 hour Brain tumor mass effect secondary hemorrhage brain surgery Pregnancy Confounding condition injury Spinal cord injury Sustained high blood pressure arterial oxygen saturation</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>TBI</keyword>
	<keyword>closed head injury</keyword>
	<keyword>severe head trauma</keyword>
	<keyword>traumatic brain injury</keyword>
</DOC>